Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

The Promising Role of Tucatinib in HER2-Positive Breast Cancer Therapy

Sherene Loi MD, PhD, Consultant Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the HER2CLIMB study and the promising role of tucatinib in the treatment of metastatic, HER2-positive breast cancer.

 

Advertisement

Advertisement

Advertisement

Advertisement